AR ANALYSIS AND FOLLOW-UP
Accounts Receivable Governance That Keeps Revenue Moving
Aging accounts receivable is not a cash flow problem — it is a control problem. Every dollar sitting beyond 90 days in AR represents a claim that has not been resolved, a follow-up that has not happened, or a payer that has not been held accountable. Left unmanaged, AR aging becomes a permanent write-off.
QWay Healthcare governs AR through systematic follow-up protocols, payer-specific escalation workflows, and AI tools that surface high-risk balances before they become uncollectable.
The financial exposure in an unmanaged AR portfolio grows silently. By the time leadership sees it in a report, significant write-off potential has already developed.
The Financial Impact of AR Aging
Claims beyond 90 days have a materially lower collection probability than claims worked within 30 days.
For a $15M practice with AR days running at 65, the difference between that performance and a 40-day benchmark represents roughly $3.1M in additional cash tied up in the AR portfolio — cash that should have already posted.
A 15-day improvement in AR days on $15M in annual revenue may generate:
$617,000 in accelerated cash collections
Reduced write-off exposure on aged claim balances
Lower cost to collect as follow-up volume decreases
Improved operating cash flow for financial planning
Industry Benchmarks for AR Performance
High-performing organizations operate within these ranges:
AR days (net): under 40
Percentage of AR over 90 days: under 15%
Percentage of AR over 120 days: Under 10%
Collection rate (net): 95 to 98%
Write-off rate: under 1% of net patient revenue
Where the Problem Starts
AR aging accelerates when follow-up is inconsistent. Claims submitted and not responded to within expected timelines need active follow-up — but most billing teams do not have a system that surfaces them on time, assigns them by payer, and tracks them to resolution.
The secondary failure is payer intelligence. Different payers have different adjudication timelines, escalation paths, and documentation requirements for follow-up. A team without payer-specific knowledge defaults to generic follow-up that delays resolution and erodes collection probability.
How QWay Healthcare Controls For AR Analysis
Systematic Follow-Up Protocols
Every claim in the AR portfolio is assigned a follow-up trigger based on payer-specific expected adjudication timelines — not arbitrary buckets.
Payer-Specific Escalation
QWay’s teams apply escalation workflows matched to each payer’s process, reducing round-trip times and preventing claims from sitting in adjudication limbo.
AI-Assisted Balance Surfacing
Machine learning tools identify high-risk AR balances by age, payer, and claim type, prioritizing follow-up where write-off risk is highest.
Aging Bucket Analysis
AR portfolios are analyzed weekly against 30/60/90/120-day benchmarks, with corrective action on outliers before they compound.
Denial-to-Follow-Up Integration
Denied claims generating additional AR aging are flagged for simultaneous appeal and follow-up workflows.
Root Cause Identification
Repeat AR aging patterns by payer or claim type, surface upstream billing issues that are corrected at the source.
Revenue Exposure Categories Addressed
- Payer non-response
- Secondary claim delays
- Authorization-related holds
- Incorrect payment postings
- Underpayment identification
- Stalled adjudication